• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应对巴塞罗那脂肪性肝病公共卫生威胁的行动呼吁。

A call to action to address the steatotic liver disease public health threat in Barcelona.

作者信息

Lazarus Jeffrey V, Miralles-Sanchez J Emilio, Agirre-Garrido Leire, Brachowicz Nicolai, Nicolàs Aina, Armenta Anthony, Boudou Delfina, Rice-Duek Lisa, Pericàs Juan M, Benach Joan, Kopka Christopher J, Wajcman Dana Ivancovsky

机构信息

Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.

Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.

出版信息

Lancet Reg Health Eur. 2025 Mar 22;52:101272. doi: 10.1016/j.lanepe.2025.101272. eCollection 2025 May.

DOI:10.1016/j.lanepe.2025.101272
PMID:40207291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11979978/
Abstract

Despite their high prevalence worldwide, steatotic liver diseases (SLDs) are largely excluded from most non-communicable disease (NCD) guidelines and strategies. We propose policies and strategies to achieve the United Nations Sustainable Development Goal of reducing NCD premature mortality by one-third by 2030. To assess this gap-the exclusion of SLDs from NCD policies-in urban areas, we reviewed Barcelona's strategies for NCD risks (e.g., alcohol, tobacco, healthy food access). We then explored applications of geo-spatial visualisation and whole-of-society approaches (e.g., citizen science engagement) aligned with the World Health Organization (WHO) Best Buys to provide recommendations to address NCDs, generally, and SLDs specifically.

摘要

尽管脂肪性肝病(SLDs)在全球范围内普遍存在,但大多数非传染性疾病(NCD)指南和策略在很大程度上都将其排除在外。我们提出了政策和策略,以实现联合国可持续发展目标,即到2030年将非传染性疾病过早死亡率降低三分之一。为了评估城市地区非传染性疾病政策中对脂肪性肝病的这种排除差距,我们回顾了巴塞罗那应对非传染性疾病风险(如酒精、烟草、健康食品获取)的策略。然后,我们探索了与世界卫生组织(WHO)的最佳实践相一致的地理空间可视化和全社会方法(如公民科学参与)的应用,以提供针对一般非传染性疾病,特别是脂肪性肝病的应对建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b348/11979978/26be8d853ce8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b348/11979978/d8a86213652c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b348/11979978/26be8d853ce8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b348/11979978/d8a86213652c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b348/11979978/26be8d853ce8/gr2.jpg

相似文献

1
A call to action to address the steatotic liver disease public health threat in Barcelona.应对巴塞罗那脂肪性肝病公共卫生威胁的行动呼吁。
Lancet Reg Health Eur. 2025 Mar 22;52:101272. doi: 10.1016/j.lanepe.2025.101272. eCollection 2025 May.
2
Implementation of national policies and interventions (WHO Best Buys) for non-communicable disease prevention and control in Ghana: a mixed methods analysis.加纳实施非传染性疾病预防和控制的国家政策和干预措施(世卫组织最佳购买):混合方法分析。
Health Res Policy Syst. 2024 Nov 15;22(1):154. doi: 10.1186/s12961-024-01242-3.
3
Non-communicable diseases in the WHO African region: analysis of risk factors, mortality, and responses based on WHO data.世界卫生组织非洲区域的非传染性疾病:基于世界卫生组织数据的风险因素、死亡率及应对措施分析
Sci Rep. 2025 Apr 10;15(1):12288. doi: 10.1038/s41598-025-97180-3.
4
NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4.NCD 倒计时 2030:全球非传染性疾病死亡率趋势及实现可持续发展目标 3.4 目标进展。
Lancet. 2018 Sep 22;392(10152):1072-1088. doi: 10.1016/S0140-6736(18)31992-5. Epub 2018 Sep 20.
5
Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.1990-2017 年 195 个国家和地区可避免的非传染性疾病过早死亡率趋势:基于人群的研究。
Lancet Glob Health. 2020 Apr;8(4):e511-e523. doi: 10.1016/S2214-109X(20)30035-8.
6
The 2023 Latin America report of the Countdown on health and climate change: the imperative for health-centred climate-resilient development.《2023年健康与气候变化倒计时拉丁美洲报告:以健康为中心的气候适应型发展的必要性》
Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May.
7
Contextual factors in premature non-communicable disease mortality in selected African countries within the sustainable development goals framework: the implication of voice and accountability.可持续发展目标框架下部分非洲国家过早非传染性疾病死亡的背景因素:发言权与问责制的影响
J Public Health Afr. 2022 Jul 27;13(2):1929. doi: 10.4081/jphia.2022.1929. eCollection 2022 Jul 26.
8
Mitigating the Rising Burden of Non-Communicable Diseases through Locally Generated Evidence-Lessons from Tanzania.通过本地生成的证据减轻非传染性疾病负担——来自坦桑尼亚的经验教训。
Ann Glob Health. 2023 Nov 17;89(1):77. doi: 10.5334/aogh.4111. eCollection 2023.
9
The state of diet-related NCD policies in Afghanistan, Bangladesh, Nepal, Pakistan, Tunisia and Vietnam: a comparative assessment that introduces a 'policy cube' approach.阿富汗、孟加拉国、尼泊尔、巴基斯坦、突尼斯和越南与饮食相关的非传染性疾病政策现状:引入“政策魔方”方法的比较评估。
Health Policy Plan. 2020 Jun 1;35(5):503-521. doi: 10.1093/heapol/czz175.
10
Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.健康人群与健康利润?构建一个用于管控非传染性疾病商业决定因素的概念框架并确定降低风险暴露的选项。
Global Health. 2017 Jun 15;13(1):34. doi: 10.1186/s12992-017-0255-3.

本文引用的文献

1
Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes: a narrative review.基于人群的政策在减轻2型糖尿病负担方面的有效性和公平性证据:一项叙述性综述。
Diabetologia. 2025 Feb;68(2):281-294. doi: 10.1007/s00125-024-06330-1. Epub 2024 Dec 2.
2
Assessing the built environment through photographs and its association with obesity in 21 countries: the PURE Study.通过照片评估建筑环境及其与 21 个国家肥胖的关系:纯粹研究。
Lancet Glob Health. 2024 Nov;12(11):e1794-e1806. doi: 10.1016/S2214-109X(24)00287-0. Epub 2024 Sep 27.
3
Epidemiology of metabolic dysfunction-associated steatotic liver disease.
代谢功能障碍相关脂肪性肝病的流行病学
Clin Mol Hepatol. 2025 Feb;31(Suppl):S32-S50. doi: 10.3350/cmh.2024.0431. Epub 2024 Aug 19.
4
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease.低至中度饮酒与代谢功能障碍相关脂肪性肝病患者的纤维化增加有关。
J Hepatol. 2024 Dec;81(6):930-940. doi: 10.1016/j.jhep.2024.06.036. Epub 2024 Jul 4.
5
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).EASL-EASD-EASO 临床实践指南:代谢功能障碍相关脂肪性肝病(MASLD)的管理。
J Hepatol. 2024 Sep;81(3):492-542. doi: 10.1016/j.jhep.2024.04.031. Epub 2024 Jun 7.
6
Preventing liver disease with policy measures to tackle alcohol consumption and obesity: The HEPAHEALTH II study.用解决酒精消费和肥胖问题的政策措施预防肝病:HEPAHEALTH II 研究。
J Hepatol. 2024 Apr;80(4):543-552. doi: 10.1016/j.jhep.2023.11.021. Epub 2023 Dec 11.
7
Implementation of a liver health check in people with type 2 diabetes.对2型糖尿病患者进行肝脏健康检查
Lancet Gastroenterol Hepatol. 2024 Jan;9(1):83-91. doi: 10.1016/S2468-1253(23)00270-4.
8
Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes.公共卫生政策对酒精与全球癌症、肝脏疾病和心血管疾病结局的关联。
J Hepatol. 2024 Mar;80(3):409-418. doi: 10.1016/j.jhep.2023.11.006. Epub 2023 Nov 21.
9
Impact of the WHO "best buys" for alcohol policy on consumption and health in the Baltic countries and Poland 2000-2020.2000 - 2020年世界卫生组织酒精政策“最佳采购建议”对波罗的海国家和波兰酒精消费及健康的影响
Lancet Reg Health Eur. 2023 Aug 31;33:100704. doi: 10.1016/j.lanepe.2023.100704. eCollection 2023 Oct.
10
Citizen science for monitoring the health and well-being related Sustainable Development Goals and the World Health Organization's Triple Billion Targets.公民科学在监测与健康和福祉相关的可持续发展目标和世界卫生组织的“三亿目标”中的应用。
Front Public Health. 2023 Aug 9;11:1202188. doi: 10.3389/fpubh.2023.1202188. eCollection 2023.